Blutstammzelltransplantation bei Mukopolysaccharidose Typ 1H (Morbus Hurler)

Aversa F, Tabilio A, Velardi A et al. (1998) Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 339:1186–1193 Baxter MA, Wynn RF, Deakin JA et al. (2002) Retrovirally mediated correction of bone marrow-derived mesenchymal stem cells from patients with mucopolysaccharidosis type I. Blood 99:1857–1859 Beck M (2001) Variable clinical presentation in lysosomal storage disorders. J Inherit Metab Dis (Suppl 2) 24:47–51 Dangel JH (1998) Cardiovascular changes in children with mucopolysaccharide storage diseases and related disorders—clinical and echocardiographic findings in 64 patients. Eur J Pediatr 157:534–538 Field RE, Buchanan JA, Copplemans MG et al. (1994) Bone-marrow transplantation in Hurler’s syndrome. Effect on skeletal development. J Bone Joint Surg Br 76:975–981 Fratantoni JC, Hall CW, Neufeld EF (1968) The defect in Hurler’s and Hunter’s syndromes: faulty degradation of mucopolysaccharide. Proc Natl Acad Sci USA 60:699–706 Gaipa G, Dassi M, Perseghin P et al. (2003) Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases. Bone Marrow Transplant 31:857–860 Grewal SS, Krivit W, Defor TE et al. (2002) Outcome of second hematopoietic cell transplantation in Hurler syndrome. Bone Marrow Transplant 29:491–496 Guffon N, Souillet G, Maire I et al. (1998) Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 133:119–125 Handgretinger R, Schumm M, Lang P et al. (1999) Transplantation of megadoses of purified haploidentical stem cells. Ann N Y Acad Sci 872:351–361 Hobbs JR, Hugh-Jones K, Barrett AJ et al. (1981) Reversal of clinical features of Hurler’s disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 2:709–712 Hurler G (1919) Über einen Typ multipler Abartungen, vorwiegend am Skelettsystem. Z Kinderheilkd 24:220–224 Johnson MA, Desai S, Hugh-Jones K et al. (1984) Magnetic resonance imaging of the brain in Hurler syndrome. Am J Neuroradiol 5:816–819 Kakkis ED, Muenzer J, Tiller GE et al. (2001) Enzyme-replacement therapy in mucopolysaccharidosis I. N Engl J Med 344:182–188 Kapelushnik J, Mandel H, Varadi G et al. (2000) Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome. J Pediatr Hematol Oncol 22:433–436 Koc ON, Day J, Nieder M et al. (2002) Allogenetic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30:215–222 Kremens B, Basu O, Peceny R et al. (2002) Allogeneic CD34+-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases. Bone Marrow Transplant 29:9–13 Krivit W, Sung JH, Lockmann LA et al. (1995) Bone marrow transplantation for treatment of lysosomal and peroxisomal storage diseases: focus on central nervous system reconstitution. In: Rich RR, Fleisher TA, Schwartz BD et al. (eds) Principles of clinical immunology, vol 2. Mosby, St. Louis, pp 1852–1864 Krivit W, Aubourg P, Shapiro E et al. (1999) Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol 6:377–382 Peters C, Shapiro EG, Krivit W (1998) Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation. Pediatr Transplant 2:250–253 Peters C, Balthazor M, Shapiro EG et al. (1996) Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 87:4894–4902 Peters C, Shapiro EG, Anderson J et al. (1998) Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. Blood 91:2601–2608 Phipps S, Mulhern R (1997) Developmental outcome of unrelated donor bone marrow transplantation in children with Hurler syndrome. Blood 89:732–734 Reisner Y, Martelli MF (2000) Transplantation tolerance induced by “mega dose” CD34+ cell transplants. Exp Hematol 28:119–127 Russell C, Hendson G, Jevon G et al. (1998) Murine MPS I: insights into the pathogenesis of Hurler syndrome. Clin Genet 53:349–361 Scott HS, Bunge S, Gal A et al. (1995) Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Hum Mutat 6:288–302 Schmidt J, Fleissner S, Heimann-Weitschat I et al. (1994) Effect of corticosteroids, cyclosporin A, and methotrexate on cytokine release from monocytes and T-cell subsets. Immunopharmacology 27:173–179 Seto T, Kono K, Morimoto K et al. (2001) Brain magnetic resonance imaging in 23 patients with mucopolysaccharidoses and the effect of bone marrow transplantation. Ann Neurol 50:79–92 Shull RM, Kakkis ED, McEntee MF et al. (1994) Enzyme replacement in a canine model of Hurler syndrome. Proc Natl Acad Sci USA 91:12937–12941 Vellodi A, Young EP, Cooper A et al. (1997) Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres. Arch Dis Child 76:92–99 Wraith JE (2001) Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. J Inherit Metab Dis 24:245–250